We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
药用真菌桑黄的种类解析.
- Authors
吴声华; 戴玉成
- Abstract
The first record on the medicinal use of “Sanghuang” date back 2 000 years to China’s The Divine Farmer’s Materia Medica, by the name “Sanger”. The term “Sanghuang” was first reported in a Chinese medicinal book The characters of drugs written by Zhen Quan in early Tang Dynasty. Sanghuang differs from other medicinal fungi in having many morphologically resembling species. The “Sanghuang” appeared in the numerous ancient books has been described by different people and actually represents different species. In ancient times it was not possible to study both microscopic morphological features and DNA sequencing, to clarify species separation. Modern research of Sanghuang originated from discovery of its excellent anti-tumor capability by the Japanese scholars in 1968. In Japan and Korea, Phellinus linteus was long adopted as the scientific binomial for the Sanghuang species. However, in 1998 the Chinese mycologists found P. linteus is distributed in Central America, not in Asia. In 2012, the genuine Sanghuang was presented as a new species, Inonotus sanghuang, grows only on Morus. In 2016, the new genus Sanghuangporus was proposed to accommodate I. sanghuang and some other closely related species, and Sanghuangporus sanghuang thus became the scientific binomial for the Sanghuang species. So far, Sanghuangporus comprises 14 species, which are generally specialized with their host tree species, and S. sanghuang is the only species grows on Morus. Pharmacological activities of S. sanghuang are better than two other commercially available species, S. baumii and S. vaninii. The cultivated fruiting bodies of the so-called Sanghuang in China, Japan and Korea, are not S. sanghuang, but S. vaninii. According to the excellent health-care effects and safety of S. sanghuang and S. vaninii, we suggest the government departments accept these two medicinal fungi in the China Pharmacopoeia, and consider the fungi as safe food stuff and Chinese herbal medicine for promoting development of the Sanghuang industry. It is essential to clearly specify the correct scientific name and Chinese name usages of these two medicinal fungi used in their products.
- Subjects
NORTH Korea; CHINA; MATERIA medica; CHINESE medicine; HERBAL medicine; NUCLEOTIDE sequence; PHELLINUS
- Publication
Mycosystema, 2020, Vol 39, Issue 5, p781
- ISSN
1672-6472
- Publication type
Article
- DOI
10.13346/j.mycosystema.190354